Correlation Between Eli Lilly and Mainz Biomed

Can any of the company-specific risk be diversified away by investing in both Eli Lilly and Mainz Biomed at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eli Lilly and Mainz Biomed into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Eli Lilly and and Mainz Biomed BV, you can compare the effects of market volatilities on Eli Lilly and Mainz Biomed and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eli Lilly with a short position of Mainz Biomed. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eli Lilly and Mainz Biomed.

Diversification Opportunities for Eli Lilly and Mainz Biomed

0.42

Correlation Coefficient

Eli Lilly  Mainz Biomed

Very weak diversification

The 3 months correlation between Eli and Mainz is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Eli Lilly and and Mainz Biomed BV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mainz Biomed BV and Eli Lilly is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eli Lilly and are associated (or correlated) with Mainz Biomed. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mainz Biomed BV has no effect on the direction of Eli Lilly i.e., Eli Lilly and Mainz Biomed go up and down completely randomly.

Pair Corralation between Eli Lilly and Mainz Biomed

Considering the 90-day investment horizon Eli Lilly is expected to generate 1.39 times less return on investment than Mainz Biomed. But when comparing it to its historical volatility, Eli Lilly and is 3.69 times less risky than Mainz Biomed. It trades about 0.06 of its potential returns per unit of risk. Mainz Biomed BV is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  460.00  in Mainz Biomed BV on December 27, 2024 and sell it today you would lose (33.00) from holding Mainz Biomed BV or give up 7.17% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Eli Lilly and  vs.  Mainz Biomed BV

Eli Lilly

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Eli Lilly and are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain essential indicators, Eli Lilly may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Mainz Biomed BV

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Mainz Biomed BV are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Mainz Biomed may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Eli Lilly and Mainz Biomed

The main advantage of trading using opposite Eli Lilly and Mainz Biomed positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eli Lilly position performs unexpectedly, Mainz Biomed can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mainz Biomed will offset losses from the drop in Mainz Biomed's long position.

The idea behind Eli Lilly and and Mainz Biomed BV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.